Data / Form D filings / PanTheryx, Inc.
PanTheryx, Inc.: Form D filings
PanTheryx, Inc., a biotechnology company in Boulder, CO, filed 17 Form D notices with the SEC between 2011 and 2023. The latest, on October 11, 2023, reports $52.3 million sold of a $60 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4845 Pearl East Circle, Suite 101, Boulder, CO, 80301
- Phone
- (303) 951-6883
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Colorado
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1416162
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 11, 2023 | New notice | $60,000,000 | $52,289,052 | $7,710,948 | 1 | Oct 2, 2023 | sec.gov |
| Apr 28, 2021 | New notice | $11,895,991 | $9,437,369 | $2,458,622 | 37 | Apr 19, 2021 | sec.gov |
| Jul 13, 2018 | New notice | $14,999,996 | $10,711,756 | $4,288,240 | 5 | Jul 3, 2018 | sec.gov |
| Sep 27, 2017 | New notice | $13,000,009 | $8,861,523 | $4,138,486 | 1 | Sep 25, 2017 | sec.gov |
| Apr 28, 2015 | Amendment | $10,000,000 | $9,260,818 | $739,182 | 37 | Apr 12, 2013 | sec.gov |
| Jan 21, 2015 | Amendment | $10,000,000 | $7,323,328 | $2,676,672 | 35 | Apr 12, 2013 | sec.gov |
| May 21, 2014 | Amendment | $10,000,000 | $5,027,873 | $4,972,127 | 27 | Apr 12, 2013 | sec.gov |
| Apr 17, 2014 | Amendment | $10,000,000 | $5,027,873 | $4,972,127 | 25 | Apr 12, 2013 | sec.gov |
| Apr 9, 2014 | Amendment | $10,000,000 | $4,427,873 | $5,572,127 | 25 | Apr 12, 2013 | sec.gov |
| Mar 25, 2014 | Amendment | $10,000,000 | $4,350,873 | $5,649,127 | 23 | Apr 12, 2013 | sec.gov |
| May 3, 2013 | New notice | $10,000,000 | $1,439,858 | $8,560,142 | 10 | Apr 12, 2013 | sec.gov |
| Aug 20, 2012 | Amendment | $4,000,000 | $3,541,100 | $458,900 | 26 | Feb 14, 2012 | sec.gov |
| Apr 24, 2012 | New notice | $4,000,000 | $1,566,100 | $2,433,900 | 14 | Feb 14, 2012 | sec.gov |
| Dec 8, 2011 | Amendment | $1,625,805 | $1,625,805 | 15 | Dec 30, 2010 | sec.gov | |
| Jun 23, 2011 | Amendment | $1,300,000 | $800,005 | $499,995 | 5 | Dec 30, 2010 | sec.gov |
| Mar 18, 2011 | Amendment | $1,000,000 | $450,000 | $550,000 | 3 | Dec 30, 2010 | sec.gov |
| Jan 10, 2011 | New notice | $1,000,000 | $180,000 | $820,000 | 3 | Dec 30, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| N Stuart Harris | Director | |
| David Cogut | Director | |
| Holger Liepmann | Director | |
| Thomas Stuart Feeley | Executive Officer | |
| Wes Parris | Executive Officer, Director | |
| David Abramson | Director | |
| Peter Erickson | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Oct 9, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PanTheryx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.